Financhill
Back

Enfusion Quote, Financials, Valuation and Earnings

Enfusion Price Quote

$9.70
+0.20 (+2.11%)
(Updated: November 13, 2024 at 5:55 PM ET)

Enfusion Key Stats

Buy
56
Enfusion (ENFN) is a Buy

Day range:
$9.45 - $9.59
52-week range:
$7.52 - $10.45
Dividend yield:
0%
P/E ratio:
135.71
P/S ratio:
5.78
P/B ratio:
12.82%

Volume:
238K
Avg. volume:
350.2K
1-year change:
0.74%
Market cap:
$896.5M
Revenue:
$174.5M
EPS:
$0.04

How Much Does Enfusion Make?

  • How Much Are Enfusion's Sales Annually?
    ENFN Revenues are $174.5M
  • How Much Profit Does Enfusion's Make A Year?
    ENFN net income is $6M

Is Enfusion Growing As A Company?

  • What Is Enfusion's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.15%
  • What Is Enfusion's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Enfusion Stock Price Performance

  • Did Enfusion Stock Go Up Last Month?
    Enfusion share price went up by 5.67% last month
  • Did ENFN's Share Price Rise Over The Last Year?
    ENFN share price rose by 0.74% over the past 1 year

What Is Enfusion 52-Week High & Low?

  • What Is Enfusion’s 52-Week High Share Price?
    Enfusion has traded as high as $10.45 over the past 52 weeks
  • What Is Enfusion’s 52-Week Low Share Price?
    Enfusion has traded as low as $7.52 over the past 52 weeks

Enfusion Price To Free Cash Flow

  • Is Enfusion Stock Overvalued?
    Enfusion is trading at a price to free cash flow ratio of 53.53
  • Is Enfusion Stock Undervalued?
    Enfusion EV to Free Cash Flow ratio is 41.50
  • What Is Enfusion’s Price Earnings Growth Ratio?
    ENFN PEG ratio is 0.00
  • Is Enfusion Trading At A Premium To Earnings?
    Enfusion EV to EBIT ratio is 130.42

Is It Risky To Buy Enfusion?

  • How Much Debt Does Enfusion Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Enfusion Have?
    Cash and short term investments quarterly total is $48.3M
  • What Is Enfusion’s Book Value Per Share?
    Book value per share is 0.75

Is Enfusion Cash Flow Positive?

  • What Is ENFN Cash Flow From Operations?
    Cash flow from operations (TTM) is $31.6M
  • What Is Enfusion’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$2M
  • What Is Enfusion’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$13.5M

Enfusion Return On Invested Capital

  • Is Management Doing A Good Job?
    ENFN return on invested capital is 3.97%
  • What Is Enfusion Return On Assets?
    ROA measures how assets are converting to revenues and is 2.88%
  • What Is ENFN Return On Equity?
    ROE is a measure of profitability and is 3.97%

Enfusion Earnings Date & Stock Price

  • What Is Enfusion's Stock Price Today?
    A single share of ENFN can be purchased today for 9.50
  • What Is Enfusion’s Stock Symbol?
    Enfusion trades on the nyse under the ticker symbol: ENFN
  • When Is Enfusion’s Next Earnings Date?
    The next quarterly earnings date for Enfusion is scheduled on March 12, 2025
  • When Is ENFN's next ex-dividend date?
    Enfusion's next ex-dividend date is November 14, 2024
  • How To Buy Enfusion Stock?
    You can buy Enfusion shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Enfusion Competitors

  • Who Are Enfusion's Competitors?
    Below is a list of companies who compete with Enfusion or are related in some way:
    • BM Technologies Inc (BMTX)
    • Castellum Inc (CTM)
    • Cognizant Technology Solutions Corp (CTSH)
    • F5 Inc (FFIV)
    • Marti Technologies Inc (MRT)

Enfusion Dividend Yield

  • What Is ENFN Dividend Yield?
    Enfusion’s dividend yield currently is 0%
  • What Is Enfusion’s Payout Ratio?
    Enfusion’s payout ratio is 0%
  • When Did Enfusion Last Pay A Dividend?
    The latest dividend pay date is November 14, 2024
  • What Is Enfusion’s Dividend Per Share?
    Enfusion pays a dividend of $0.00 per share

Enfusion Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -11.88%
Revenue: 15.35% -1.92%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 9.61
Upside from Last Price: 1.17%

Major Shareholders

  • How many ENFN shares are owned by institutional investors?
    77.5M ENFN shares are owned by institutional investors
  • How many ENFN shares are owned by insiders?
    3.6M ENFN shares are owned by insiders